nVerses Capital’s Axogen AXGN Stock Holding History

nVerses Capital’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,000	Closed	-$56.1K	–	96
2024 Q3	$56.1K	Buy	+4,000	New	+$44.2K	0.03%	603

Other funds holding AXGN

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

nVerses Capital's AXGN Position: Q4 2024 in Review

nVerses Capital sold out of Axogen (AXGN) in Q4 2024, closing a stake of 4,000 shares — an estimated $56.1K sold.

nVerses Capital first reported a position in AXGN in Q3 2024 and held it in 1 quarter. The position peaked at $56.1K in Q3 2024. 172 funds tracked by Wall St. Rank hold AXGN as of Q4 2024.

nVerses Capital reported no remaining Axogen position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 4,000 Axogen shares in Q4 2024, an estimated $56.1K.
nVerses Capital first reported a position in Axogen in Q3 2024 and held it in 1 quarter.
nVerses Capital's Axogen position peaked at $56.1K in Q3 2024.
172 funds tracked by Wall St. Rank held Axogen as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.